EBV/LMP-specific T cells maintain remissions of T- and B-cell EBV lymphomas after allogeneic bone marrow transplantation-Reference-Cited by-同舟云学术

EBV/LMP-specific T cells maintain remissions of T- and B-cell EBV lymphomas after allogeneic bone marrow transplantation

Published:2018-11-29 Issue:22 Volume:132 Page:2351-2361
ISSN:0006-4971
Container-title:Blood
language:en
Short-container-title:

Author:

McLaughlin Lauren P.¹,Rouce Rayne²,Gottschalk Stephen²³⁴,Torrano Vicky²,Carrum George²⁵,Wu Meng-Fen³,Hoq Fahmida¹,Grilley Bambi²,Marcogliese Andrea M.⁶,Hanley Patrick J.¹,Gee Adrian P.²³⁴,Brenner Malcolm K.²³⁷,Rooney Cliona M.²³⁴⁵⁸,Heslop Helen E.²³⁷,Bollard Catherine M.¹²³⁴⁵

Affiliation:

1. Center for Cancer and Immunology Research, Children’s National Health System and George Washington University, Washington, DC;

2. Center for Cell and Gene Therapy, Baylor College of Medicine, Houston Methodist Hospital, and Texas Children's Hospital, Houston, TX; and

3. Dan L. Duncan Comprehensive Cancer Center,

4. Department of Pediatrics,

5. Department of Immunology,

6. Department of Pathology,

7. Department of Medicine, and

8. Department of Virology, Baylor College of Medicine, Houston, TX

Abstract

Abstract There is a Blood Commentary on this article in this issue.

Publisher